MoneyWorks4Me

Smruthi Organics - Quaterly Results

14 Feb 2026 Evaluate
The sales for the December 2025 quarter moved down to Rs. 222.91 millions as compared to Rs. 312.50 millions during the year-ago period.The Net proft of the company remain more or less same to Rs. 13.96  millions from Rs. 14.82 millions ,decline by -5.80%.A decline of 40.09 millions was observed in the OP in the quarter ended December 2025 from 41.68 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 222.91 312.50 -28.67 728.78 879.14 -17.10 1260.08 1276.43 -1.28
Other Income 0.08 0.04 100.00 1.06 0.13 715.38 0.89 0.76 17.11
PBIDT 40.09 41.68 -3.81 93.47 75.18 24.33 122.71 120.31 1.99
Interest 2.53 5.08 -50.20 13.75 13.54 1.55 18.70 14.08 32.81
PBDT 33.04 36.60 -9.73 75.20 61.64 22.00 104.01 106.23 -2.09
Depreciation 16.73 13.70 22.12 45.95 39.97 14.96 55.01 56.53 -2.69
PBT 16.31 22.90 -28.78 29.25 21.67 34.98 49.00 49.70 -1.41
TAX 2.35 8.08 -70.92 5.67 8.32 -31.85 13.37 13.79 -3.05
Deferred Tax -0.64 0.40 -260.00 -2.52 -0.52 384.62 -0.32 -2.27 -85.90
PAT 13.96 14.82 -5.80 23.58 13.35 76.63 35.63 35.91 -0.78
Equity 114.46 114.46 0.00 114.46 114.46 0.00 114.46 114.46 0.00
PBIDTM(%) 17.98 13.34 34.84 12.83 8.55 49.98 9.74 9.43 3.32
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..